Analysts Set Sotera Health Company (NASDAQ:SHC) Target Price at $16.00

Shares of Sotera Health Company (NASDAQ:SHC - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $16.00.

A number of equities research analysts have recently issued reports on the company. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Barclays reduced their price objective on Sotera Health from $15.00 to $13.00 and set an "overweight" rating for the company in a report on Tuesday, June 24th. Piper Sandler reduced their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Finally, Wall Street Zen upgraded Sotera Health from a "hold" rating to a "buy" rating in a report on Saturday, June 28th.

Institutional Investors Weigh In On Sotera Health

Several institutional investors have recently made changes to their positions in SHC. Quarry LP bought a new stake in shares of Sotera Health in the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of Sotera Health by 3,690.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock valued at $31,000 after buying an additional 2,620 shares during the period. Summit Securities Group LLC bought a new stake in shares of Sotera Health in the first quarter valued at approximately $67,000. Farther Finance Advisors LLC boosted its stake in shares of Sotera Health by 4,881.9% in the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock valued at $70,000 after buying an additional 6,200 shares during the period. Finally, Tower Research Capital LLC TRC boosted its stake in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after buying an additional 1,640 shares during the period. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Up 0.9%

Shares of SHC traded up $0.11 during midday trading on Wednesday, hitting $11.75. The stock had a trading volume of 425,726 shares, compared to its average volume of 1,234,530. The company has a 50 day simple moving average of $12.07 and a two-hundred day simple moving average of $12.33. Sotera Health has a twelve month low of $9.53 and a twelve month high of $17.08. The firm has a market cap of $3.33 billion, a price-to-earnings ratio of 146.83 and a beta of 1.81. The company has a debt-to-equity ratio of 5.55, a current ratio of 2.46 and a quick ratio of 2.19.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. The business had revenue of $254.52 million for the quarter, compared to the consensus estimate of $245.56 million. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. Sotera Health's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.13 earnings per share. On average, analysts anticipate that Sotera Health will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.